Daily stock price downward movements for Eledon Pharmaceuticals are typically triggered by broader market corrections across small-cap biotechnology equities, sector-specific profit-taking, or shifts in investor sentiment regarding clinical trial timelines and capital requirements. Because pre-revenue biotech companies lack commercial product revenue streams, minor fluctuations in daily trading volume or broader macro sentiment can cause short-term pullbacks in share valuations.